德國欣髮源 Thymuskin

在多中心實驗的一部分中，耐受性和化妝品接受度，也在雄激素性落髮和慢性休止期落髮的患者身上測試。

•耐受性在50％的受試者身上表現優異；42％的表現良好

•過程中無副作用導致治療終止

•化妝品接受度在45％受試者身上表現優異，43％良好，10％滿意，2％表現較差。

耐受性和化妝品接受度的評估

德國欣髮源 THYMUSKIN® 對雄激素性落髮或慢性休止期落髮患者的耐受性評估

»約 90％的患者在耐受性和化妝品接受度評估上顯示良好或優良

原文：

Good to excellent tolerability and cosmetic acceptance

As part of the multicentric study named above8, tolerability and cosmetic acceptance were also evaluated in both patients with androgenetic alopecia and patients with chronic telogen effluvium.

• Tolerability was excellent in 50% of patients and good in 42%

• No side effects resulting in termination of treatment were identified

• Cosmetic acceptance was excellent in 45% of patients, good in 43%, satisfactory in 10% and poor in 2%

Thymuski n® tolerability in patients with androgenetic alopecia or chronic telogen effluvium

»» Approx. 90% of patients rated tolerability and cosmetic acceptance as good or excellent